![Dan Littman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dan Littman
Direktor/Vorstandsmitglied bei
PFIZER INC.
Vermögen: - $ am 31.05.2026
Profil
Dan R.
Littman is the founder of Vedanta Biosciences, Inc., founded in 2010; Orca Pharmaceuticals Ltd., founded in 2012; and Immunai, Inc., founded in 2018.
Dr. Littman currently serves as an Independent Director at Pfizer Inc. since 2018, is a member of the Scientific Advisory Board at ChemoCentryx, Inc., a member of the National Academy of Sciences, a member of the National Academy of Medicine (United States), a Venture Partner at Catalio Capital Management LP, and a Professor at NYU Langone Health since 1995.
Dr. Littman was a Professor at The University of California, San Francisco from 1985 to 1995.
Dr. Littman completed undergraduate education at Princeton University and earned a doctorate from Washington University School of Medicine.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
PFIZER INC. -.--% | 23.04.2026 | 0 ( -.--% ) | - $ | 31.05.2026 |
Aktive Positionen von Dan Littman
| Unternehmen | Position | Beginn |
|---|---|---|
| PFIZER INC. | Direktor/Vorstandsmitglied | 05.03.2018 |
| CHEMOCENTRYX, INC. | Berater | - |
Vedanta Biosciences, Inc.
 Vedanta Biosciences, Inc. BiotechnologyHealth Technology Develops microbial therapies that address the human immune system | Gründer | 01.01.2010 |
National Academy of Sciences
 National Academy of Sciences Miscellaneous Commercial ServicesCommercial Services Operates as a private, nongovernmental institution that advises on issues related to science and technology | Corporate Officer/Principal | - |
National Academy of Medicine (United States)
 National Academy of Medicine (United States) Miscellaneous Commercial ServicesCommercial Services Operates as a professional membership organization | Corporate Officer/Principal | - |
NYU Langone Health
 NYU Langone Health Medical/Nursing ServicesHealth Services Provides medical services | Corporate Officer/Principal | 01.01.1995 |
Immunai, Inc.
 Immunai, Inc. Packaged SoftwareTechnology Services Develops immune system technology to treat oncology diseases | Gründer | 01.12.2018 |
Catalio Capital Management LP
 Catalio Capital Management LP Investment ManagersFinance Catalio Capital invests in public and private companies located in the United States. The firm targets companies operating in the fields of life sciences developing next-generation drugs, devices and diagnostics, data, tools and innovative healthcare sectors. It provides financing for seed, early and later stage capital requirements and also makes co-investments. | Private Equity Investor | - |
Ehemalige bekannte Positionen von Dan Littman
| Unternehmen | Position | Ende |
|---|---|---|
The University of California, San Francisco
 The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01.01.1995 |
| ░░░░ ░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░ | - |
Ausbildung von Dan Littman
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
94
Beziehungen ersten Grades
12
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 12 |
|---|---|
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
ChemoCentryx, Inc.
 ChemoCentryx, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes small molecule therapeutics for inflammatory, autoimmune diseases and cancer | Health Technology |
Orca Pharmaceuticals Ltd.
 Orca Pharmaceuticals Ltd. BiotechnologyHealth Technology Develops oral drugs for the treatment of chronic inflammatory disease | Health Technology |
Princeton University
 Princeton University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of California, San Francisco
The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
National Academy of Sciences
National Academy of Sciences Miscellaneous Commercial ServicesCommercial Services Operates as a private, nongovernmental institution that advises on issues related to science and technology | Commercial Services |
National Academy of Medicine (United States)
National Academy of Medicine (United States) Miscellaneous Commercial ServicesCommercial Services Operates as a professional membership organization | Commercial Services |
Vedanta Biosciences, Inc.
Vedanta Biosciences, Inc. BiotechnologyHealth Technology Develops microbial therapies that address the human immune system | Health Technology |
NYU Langone Health
NYU Langone Health Medical/Nursing ServicesHealth Services Provides medical services | Health Services |
Washington University School of Medicine
 Washington University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Immunai, Inc.
Immunai, Inc. Packaged SoftwareTechnology Services Develops immune system technology to treat oncology diseases | Technology Services |
Catalio Capital Management LP
Catalio Capital Management LP Investment ManagersFinance Catalio Capital invests in public and private companies located in the United States. The firm targets companies operating in the fields of life sciences developing next-generation drugs, devices and diagnostics, data, tools and innovative healthcare sectors. It provides financing for seed, early and later stage capital requirements and also makes co-investments. | Finance |
